British Smaller Companies VCT2 plc
Interim Management Statement
For the quarter ended 30 September 2013
British Smaller Companies VCT2 plc (the "Company") presents its interim management statement for the quarter ended 30 September 2013. The statement also includes relevant financial information between the end of the quarter and the date of this statement. This constitutes the Company's second interim management statement for the financial year ending 31 December 2013, as required by Rule 4.3 of the Disclosure and Transparency Rules. A copy of this interim management statement can be found at www.yfmep.com.
Performance
The total return at 30 September 2013, calculated by reference to the Net Asset Value (NAV) per ordinary share and the cumulative dividends paid per ordinary share, was 104.6 pence per ordinary share compared to 102.3 pence per ordinary share at 30 June 2013. Cumulative dividends represent 39.0 pence per ordinary share (30 June 2013: 37.0 pence per ordinary share).
The unaudited NAV per ordinary share as at 30 September 2013 was 65.6 pence (30 June 2013: 65.3 pence per ordinary share) representing an increase of 2.3 pence per ordinary share prior to the payment of the interim dividend of 2.0 pence per ordinary share on 27 September 2013. The increase in NAV per ordinary share is principally due to the net upward movement, in both the AIM quoted and unquoted portfolio valuations seen during the quarter.
The number of ordinary shares in issue at 30 September 2013 was 46,588,563 (30 June 2013: 46,371,537). In addition, at 30 September 2013, the Company held 1,632,722 ordinary shares in treasury (30 June 2013: 1,632,722).
Share Issues
During the period the Company has issued 217,026 ordinary shares at a price of 60.14 pence per share, pursuant to the Company's Dividend Re-investment Scheme (DRIS).
Net assets at 30 September 2013 comprised the following:
|
£000 |
% of net assets |
|
|
|
Unquoted investments at fair value |
12,064 |
39.5% |
Quoted investments at bid price |
2,403 |
7.9% |
Gilt investments |
898 |
2.9% |
Total investments |
15,365 |
50.3% |
|
|
|
Cash and cash equivalents |
6,926 |
22.6% |
Cash on fixed term deposit |
8,000 |
26.2% |
Other net current assets |
275 |
0.9% |
Net assets |
30,566 |
100% |
The investment portfolio at 30 September 2013 was comprised as follows:
|
Carrying cost £000 |
Valuation £000 |
Valuation as a % of net assets |
Displayplan Holdings Limited |
700 |
2,119 |
6.93% |
Douglas Gill International Limited |
1,870 |
1,870 |
6.12% |
Seven Technologies Holdings Limited |
1,238 |
1,548 |
5.06% |
Deep-Secure Ltd |
500 |
1,000 |
3.27% |
Immunobiology Limited |
1,932 |
987 |
3.23% |
Insider Technologies (Holdings) Limited |
780 |
806 |
2.64% |
Bagel Nash Group Limited |
807 |
757 |
2.48% |
Bluebell Telecom Group Limited |
484 |
721 |
2.36% |
Waterfall Services Limited |
192 |
587 |
1.92% |
PowerOasis Limited |
567 |
567 |
1.86% |
Iomart Group plc |
149 |
514 |
1.68% |
Pressure Technologies plc |
201 |
454 |
1.49% |
Harvey Jones Holdings Limited |
389 |
443 |
1.45% |
Hargreaves Services plc |
325 |
350 |
1.15% |
RMS Group Holdings Limited |
70 |
324 |
1.06% |
Selima Limited |
300 |
270 |
0.88% |
EKF Diagnostics Holdings plc |
224 |
248 |
0.81% |
AB Dynamics plc |
149 |
220 |
0.72% |
Vianet Group plc |
242 |
165 |
0.54% |
Cambridge Cognition Holdings plc |
240 |
149 |
0.49% |
Brady Public Limited Company |
134 |
134 |
0.44% |
Optos Public Limited Company |
80 |
128 |
0.42% |
Tissuemed Limited |
48 |
60 |
0.20% |
Allergy Therapeutics plc |
350 |
41 |
0.13% |
Ellfin Home Care Limited |
317 |
5 |
0.02% |
TeraView Limited |
375 |
- |
0.00% |
Total Quoted and Unquoted |
12,663 |
14,467 |
47.3% |
Gilt investments |
888 |
898 |
2.9% |
Total investments |
13,551 |
15,365 |
50.3% |
During the three months ended 30 September 2013 the Company made three investments totalling £2.47 million. These comprised one new investment of £1.87 million into Douglas Gill International Limited, a specialist provider of sailing clothing and equipment, and £0.6 million of follow- on investment into two existing portfolio companies, Bagel Nash Group Limited and Hargreaves Services plc.
In the 3 months to 30 September 2013 cash proceeds of £1.28 million were received relating to the sale of the Company's holding in Digital Healthcare Limited, generating a profit on the previous quarter's carrying value of £0.3 million. In addition £0.2 million of proceeds were received from the part disposal of the Company's holding in Pressure Technologies plc which gave rise to a profit on cost of £0.09 million in the quarter
Since the end of the quarter the Company has completed one further investment of £1.15 million into GTK Limited, a global provider and manufacturer of electronic solutions.
Portfolio Performance
Over the 3 months to 30 September 2013 the portfolio saw an overall increase in unrealised valuations of £0.83 million equating to a 6.7% increase. This comprised an increase in the value of a number of portfolio companies following strong trading results including Displayplan Holdings Limited (up £0.285 million), Pressure Technologies plc (up £0.27 million) and Seven Technologies Holdings Limited (up £0.17 million) together with resilient performances across much of the Company's remaining unquoted and AIM portfolio.
The Board continues to follow a policy of maintaining a diversified portfolio: as at 30 September 2013 only three investments represented more than 5 per cent each of the NAV of the Company with the largest investment comprising 6.9 per cent.
Outlook
The Board believes that the current economic climate continues to create investment opportunities in the short to medium term in well run and managed UK businesses that need capital to expand. Experience suggests that cautious investments made in the low point of the economic cycle have resulted in the highest portfolio returns. Following the increase in the investment limit applying to venture capital trusts to £5 million per investment in any one year there has been an increase in the number of investment opportunities presented to the Company. As a result a number of investment opportunities are currently being assessed and the Company has recently announced its intention to increase its capacity to invest in these opportunities.
25 October 2013
For further information please contact:
David Hall YFM Private Equity Limited Tel: 0113 294 5039
Matt Thomas N+1 Singer Tel: 0207 496 3000